Federated Hermes
BLUE

Federated Hermes’s bluebird bio BLUE Stock Holding History

Federated Hermes’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-241
Closed -$6.66K – 2039
2023
Q4 		$6.66K Buy
+241
New +$14.7K ﹤0.01% 1829
2023
Q2 		– Sell
-10,985
Closed -$699K – 2108
2023
Q1 		$699K Sell
10,985
-8
-0.1% -$914 ﹤0.01% 1296
2022
Q4 		$1.52M Sell
10,993
-19,626
-64% -$2.77M ﹤0.01% 1002
2022
Q3 		$3.88M Sell
30,619
-27,247
-47% -$3.08M 0.01% 727
2022
Q2 		$4.79M Buy
57,866
+12,026
+26% +$933K 0.01% 692
2022
Q1 		$4.45M Buy
45,840
+32,840
+253% +$4.33M 0.01% 813
2021
Q4 		$2.6M Sell
13,000
-325
-2% -$76.7K ﹤0.01% 984
2021
Q3 		$3.3M Buy
+13,325
New +$3.81M 0.01% 924
2021
Q1 		– Sell
-1,285
Closed -$720K – 2230
2020
Q4 		$720K Buy
1,285
+530
+70% +$336K ﹤0.01% 1432
2020
Q3 		$528K Sell
755
-27
-3% -$21.1K ﹤0.01% 1462
2020
Q2 		$618K Buy
+782
New +$590K ﹤0.01% 1422
2018
Q4 		– Sell
-386
Closed -$730K – 2202
2018
Q3 		$730K Buy
386
+154
+66% +$318K ﹤0.01% 1417
2018
Q2 		$471K Sell
232
-386
-62% -$880K ﹤0.01% 1424
2018
Q1 		$1.37M Sell
618
-1,871
-75% -$4.76M ﹤0.01% 1115
2017
Q4 		$5.74M Buy
2,489
+1,071
+76% +$2.17M 0.02% 568
2017
Q3 		$2.52M Buy
1,418
+40
+3% +$55.9K 0.01% 816
2017
Q2 		$1.88M Sell
1,378
-697
-34% -$841K 0.01% 945
2017
Q1 		$2.44M Sell
2,075
-241
-10% -$246K 0.01% 826
2016
Q4 		$1.85M Buy
2,316
+1,390
+150% +$1.1M 0.01% 900
2016
Q3 		$813K Sell
926
-1,511
-62% -$1.09M ﹤0.01% 1160
2016
Q2 		$1.37M Buy
2,437
+893
+58% +$506K ﹤0.01% 993
2016
Q1 		$850K Buy
1,544
+926
+150% +$569K ﹤0.01% 1131
2015
Q4 		$514K Hold
618
– – ﹤0.01% 1283
2015
Q3 		$684K Hold
618
– – ﹤0.01% 1195
2015
Q2 		$1.35M Hold
618
– – ﹤0.01% 1057
2015
Q1 		$966K Buy
+618
New +$815K ﹤0.01% 1189

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Federated Hermes's BLUE Position: Q1 2024 in Review

Federated Hermes sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 241 shares — an estimated $6.66K sold.

Federated Hermes first reported a position in BLUE in Q1 2015 and held it in 26 quarters. The position peaked at $5.74M in Q4 2017. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • Federated Hermes reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
  • Federated Hermes sold 241 bluebird bio shares in Q1 2024, an estimated $6.66K.
  • Federated Hermes first reported a position in bluebird bio in Q1 2015 and held it in 26 quarters.
  • Federated Hermes's bluebird bio position peaked at $5.74M in Q4 2017.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.